EP0859558B1 - Filterzigarette - Google Patents
Filterzigarette Download PDFInfo
- Publication number
- EP0859558B1 EP0859558B1 EP96937308A EP96937308A EP0859558B1 EP 0859558 B1 EP0859558 B1 EP 0859558B1 EP 96937308 A EP96937308 A EP 96937308A EP 96937308 A EP96937308 A EP 96937308A EP 0859558 B1 EP0859558 B1 EP 0859558B1
- Authority
- EP
- European Patent Office
- Prior art keywords
- filter
- additive
- cigarette according
- filter cigarette
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000019504 cigarettes Nutrition 0.000 title claims abstract description 57
- 239000000654 additive Substances 0.000 claims abstract description 58
- 230000000996 additive effect Effects 0.000 claims abstract description 51
- 230000014759 maintenance of location Effects 0.000 claims abstract description 24
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims abstract description 23
- 229960002715 nicotine Drugs 0.000 claims abstract description 23
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000000779 smoke Substances 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 18
- 239000000126 substance Substances 0.000 claims abstract description 16
- 238000000034 method Methods 0.000 claims abstract description 14
- 239000000835 fiber Substances 0.000 claims abstract description 13
- 230000002790 anti-mutagenic effect Effects 0.000 claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 claims abstract description 7
- 239000004014 plasticizer Substances 0.000 claims description 15
- 241000208125 Nicotiana Species 0.000 claims description 14
- 235000002637 Nicotiana tabacum Nutrition 0.000 claims description 14
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 claims description 14
- 229920002301 cellulose acetate Polymers 0.000 claims description 10
- 229920005610 lignin Polymers 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 8
- 235000013773 glyceryl triacetate Nutrition 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 229960002622 triacetin Drugs 0.000 claims description 7
- 229920000858 Cyclodextrin Polymers 0.000 claims description 6
- 239000001087 glyceryl triacetate Substances 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 108090000623 proteins and genes Proteins 0.000 claims description 4
- TYFQFVWCELRYAO-UHFFFAOYSA-N suberic acid Chemical compound OC(=O)CCCCCCC(O)=O TYFQFVWCELRYAO-UHFFFAOYSA-N 0.000 claims description 4
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 claims description 3
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 claims description 3
- 229920002079 Ellagic acid Polymers 0.000 claims description 3
- 239000001116 FEMA 4028 Substances 0.000 claims description 3
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 3
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 3
- 229960004853 betadex Drugs 0.000 claims description 3
- 229960002852 ellagic acid Drugs 0.000 claims description 3
- 235000004132 ellagic acid Nutrition 0.000 claims description 3
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 claims description 3
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 3
- 238000009423 ventilation Methods 0.000 claims description 3
- 150000001733 carboxylic acid esters Chemical class 0.000 claims description 2
- 239000008139 complexing agent Substances 0.000 claims description 2
- 238000010276 construction Methods 0.000 claims description 2
- 150000004696 coordination complex Chemical class 0.000 claims description 2
- 150000002148 esters Chemical class 0.000 claims description 2
- 150000004676 glycans Polymers 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 150000002894 organic compounds Chemical class 0.000 claims description 2
- 150000002989 phenols Chemical class 0.000 claims description 2
- 150000004804 polysaccharides Polymers 0.000 claims description 2
- 150000004032 porphyrins Chemical class 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims 1
- 230000000536 complexating effect Effects 0.000 claims 1
- 230000009977 dual effect Effects 0.000 claims 1
- 238000012544 monitoring process Methods 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000008107 starch Substances 0.000 claims 1
- 235000019698 starch Nutrition 0.000 claims 1
- 238000010953 Ames test Methods 0.000 abstract description 18
- 231100000039 Ames test Toxicity 0.000 abstract description 18
- 230000000391 smoking effect Effects 0.000 abstract description 5
- 239000004615 ingredient Substances 0.000 abstract description 3
- 101100379081 Emericella variicolor andC gene Proteins 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 230000009467 reduction Effects 0.000 description 9
- 230000003505 mutagenic effect Effects 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 231100000299 mutagenicity Toxicity 0.000 description 6
- 230000007886 mutagenicity Effects 0.000 description 6
- 229920002678 cellulose Polymers 0.000 description 5
- 235000010980 cellulose Nutrition 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 231100000219 mutagenic Toxicity 0.000 description 5
- 231100000243 mutagenic effect Toxicity 0.000 description 5
- 231100000150 mutagenicity / genotoxicity testing Toxicity 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 239000003471 mutagenic agent Substances 0.000 description 4
- 231100000707 mutagenic chemical Toxicity 0.000 description 4
- 230000035772 mutation Effects 0.000 description 4
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 3
- KGYXYKHTHJPEBX-UHFFFAOYSA-N 5-ethoxy-3-ethoxycarbonyl-3-hydroxy-5-oxopentanoic acid Chemical compound CCOC(=O)CC(O)(CC(O)=O)C(=O)OCC KGYXYKHTHJPEBX-UHFFFAOYSA-N 0.000 description 3
- 206010028400 Mutagenic effect Diseases 0.000 description 3
- 241000607142 Salmonella Species 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 150000004005 nitrosamines Chemical class 0.000 description 3
- -1 polycyclic aromatic amines Chemical class 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 2
- 239000003183 carcinogenic agent Substances 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- BTIJJDXEELBZFS-QDUVMHSLSA-K hemin Chemical compound CC1=C(CCC(O)=O)C(C=C2C(CCC(O)=O)=C(C)\C(N2[Fe](Cl)N23)=C\4)=N\C1=C/C2=C(C)C(C=C)=C3\C=C/1C(C)=C(C=C)C/4=N\1 BTIJJDXEELBZFS-QDUVMHSLSA-K 0.000 description 2
- 229940025294 hemin Drugs 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 239000004745 nonwoven fabric Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000197 pyrolysis Methods 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- STGNLGBPLOVYMA-KDTZGSNLSA-N (z)-but-2-enedioic acid;(e)-but-2-enedioic acid Chemical compound OC(=O)\C=C\C(O)=O.OC(=O)\C=C/C(O)=O STGNLGBPLOVYMA-KDTZGSNLSA-N 0.000 description 1
- FMMWHPNWAFZXNH-UHFFFAOYSA-N Benz[a]pyrene Chemical compound C1=C2C3=CC=CC=C3C=C(C=C3)C2=C2C3=CC=CC2=C1 FMMWHPNWAFZXNH-UHFFFAOYSA-N 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 229920006221 acetate fiber Polymers 0.000 description 1
- 150000008043 acidic salts Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001278 adipic acid derivatives Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical class OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000005470 impregnation Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000004750 melt-blown nonwoven Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 235000021135 plant-based food Nutrition 0.000 description 1
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/16—Use of materials for tobacco smoke filters of inorganic materials
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/14—Use of materials for tobacco smoke filters of organic materials as additive
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/04—Tobacco smoke filters characterised by their shape or structure
- A24D3/048—Tobacco smoke filters characterised by their shape or structure containing additives
-
- A—HUMAN NECESSITIES
- A24—TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
- A24D—CIGARS; CIGARETTES; TOBACCO SMOKE FILTERS; MOUTHPIECES FOR CIGARS OR CIGARETTES; MANUFACTURE OF TOBACCO SMOKE FILTERS OR MOUTHPIECES
- A24D3/00—Tobacco smoke filters, e.g. filter-tips, filtering inserts; Filters specially adapted for simulated smoking devices; Mouthpieces for cigars or cigarettes
- A24D3/06—Use of materials for tobacco smoke filters
- A24D3/08—Use of materials for tobacco smoke filters of organic materials as carrier or major constituent
- A24D3/10—Use of materials for tobacco smoke filters of organic materials as carrier or major constituent of cellulose or cellulose derivatives
Definitions
- the invention relates to a filter cigarette, the filter of which is an additive with an antimutagenic Contains effects on cigarette smoke.
- Antimutagenic active ingredients are known from food technology. There, many of the mutagens found in foods and their separation mechanisms are also examined and illustrated (see, inter alia, P. Grasso, CO'Hare; Chemical Carcinogens ACS Monograph (Ch.E. Searle ed.), American Chemical Society, Washington (1976), Pp. 700 - 728). Some pyrolysis products of proteins are regarded as the most effective mutagens in food today, such as the compounds Tr-P1, Tr-P2, Glu-P1, Glu-P2 or IQ (see, among others, K. Wakabayashi, M. Nagao, H. Esumi, T. Sugimura; Cancer Research, 52. (1992), pp. 2092-2098).
- mutagens show mutagenicity tests, such as the Ames test well known in the art (Ames et al., Methods for Detecting Carcinogens and Mutagens with the Salmonella / Mammalian-Microsome Mutagenicity Test., Mutat. Res. 31 , pp. 347-364 and C. Smith et al .; Mutation Research, 279 , (1992), pp. 61-73), an extremely high mutagenic potential.
- Such compounds can obviously be bound in living organisms with high efficiency in the aqueous phase to constituents of mostly plant-based foods and thus effectively removed from the metabolism as water-insoluble complex compounds.
- Such antimutagenic substances include chlorophylline and hemin and related derivatives (see, inter alia, R. Dashwood, D. Gno; Environmental and Molecular Mutagenesis, 22 , (1993), pp. 166-171, S. Arimoto, H. Hayatsu; Mutation Research, 213 , (1989), pp. 217-226, and Kato et al., Mutation Research, 246 , (1991), pp. 169-178).
- DE-PS 1 300 854 describes the use of acidic carboxylic acid alkyl esters as crosslinking or Solidifying agent. A number are based on the disclosure of this patent further writings on the use of organic acids as a filter additive to the Increase nicotine retention specifically. The special thing about this idea is that the additive also acts as a plasticizer and thus an industrial production of Filter is easily possible. However, DE-PS 1 300 854 does not disclose any indication of how mutagenic substances could be removed from cigarette smoke. The same applies also for teaching according to DE-OS 43 20 348, which also use organic acids as a filter additive.
- DE-OS 25 27 234, JP 50-125100 and JP 51-32799 describe the use of Cyclodextrin, in particular of ⁇ -cyclodextrin, for the filtration of in particular nicotine.
- This additive can be applied directly to cellulose acetate filters or as granules done in chamber filters.
- the amounts described are extremely high, 30 to 80 mg per filter after the two Japanese applications and "mainly or exclusively "according to the information in DE-OS 25 27 234. About a possible No reduction in the biological activity of the smoke is reported.
- US Pat. No. 5,409,021 describes a cigarette filter as a double or triple chamber filter, where the chamber contains lignin as a filler.
- the in the examples The amounts of effective lignin mentioned are between 22 and 66 mg.
- the known filter is specific to nicotine, benzpyrene, CO, metals and tobacco Effective in nitrosamines.
- the reduction in biological activity according to the Ames test (TA 98) is not addressed.
- the amount of additive used is approx. 20 up to 50% of the filter fiber weight.
- EP-A-0 493 026 describes the impregnation of a cellulose acetate filter with a N, N'-bis (3-triethoxysilyl-propyl) thiocarbamide monomer in concentrations of 6 to 15%. The measure results in an increased filter efficiency compared to polycyclic Aromatics, metals and tobacco-specific nitrosamines. Statements about retention of the filter used are not made. Nor will it affect the biological activity of the smoke was treated in the Ames test (TA 98).
- Russian patent 2 010 546 describes a combination of the teachings according to EP-A-0 493,026 and U.S. Patent 5,409,021.
- JP-5-23159 describes a cigarette filter with ellagic acid as an additive. Here will also addressed their antimutagenic effects.
- the amounts of additive are 1 to 10 mg per filter recommended. Its antimutagenic activity according to the Ames test (TA 98) is not proven.
- EP-A-0 246 330 describes the reduction in mutagenicity in the Ames test (TA 98) through activated cellulose powder, cellulose ion exchangers or with hemin doped celluloses in powder form.
- the examples only describe Chamber filter. The amount of powder you need to reduce the to achieve specific mutagenicity of more than 10% are well above 15%, based on the filter fiber weight used.
- the additive should also be between the Acetate fibers of a monofilter can be sprinkled in. About the effectiveness of this Measure is not specified. Reviews have shown that only with an amount of additive of significantly more than 10 mg per filter an effect in the Ames test (TA 98) of more than 10% can be achieved.
- the invention Task to propose a filter cigarette of the type described at the tobacco smoke is filtered in such a way that, according to the Ames test with the TA strain 98 measured, mutagenic substances with a selectivity of at least 10%, especially more than 20%, better than other smoke ingredients. Further the invention is intended to propose a particularly suitable method, such as the additive the filter is applied.
- the filter design is of crucial importance. It has Surprisingly, it has been shown that the effectiveness of the invention Measures a minimum retention is required with filters in today commercial cigarettes is rarely achieved. As a retention, the The present application used the nicotine retention as a guide.
- the filtration performance of a cigarette filter is next to the material properties of the Filter material from the dimensions of the filter, such as diameter and filter length, and the pressure drop in the filter (the term is used in the cigarette industry Tensile resistance to denote the pressure drop).
- the required filtration performance of a filter and here in particular the nicotine retention can be expressed by the following empirically determined equation: R N ⁇ 100 * (1-D), where R N represents nicotine retention (in percent) and D represents the permeability of the filter to nicotine.
- the variable A is calculated by subtracting the actual filter length 1 from the length of a king-size filter I o .
- the CORESTA is used for the smoke to determine the minimum retention Monitor cigarette No. 2 (see Coresta Approved Monitor No. 2 (CM2) from Fa. borgwaldt technik D - 22525 Hamburg). Because this product is only for one Diameter is defined, tobacco strands are made with other cigarette diameters identical tobacco (flue cured), strand paper, casing and tobacco density used. Since the Nicotine retention is independent of strand dimensions, and nicotine retention of cigarette filters when using flue cured tobacco is identical to the Condensate retention (G. Lipp: Contributions to Tobacco Research 3, 109 (1965)) is the Procedure for determining retention is not critical.
- Filter material is not critical. This can be the case with these materials, for example around fibers made of polypropylene, viscose, polyester and in particular cellulose Trade materials.
- Cellulose acetate is particularly preferred. You can the fibrous filter materials in the form of a filter tow or a fleece be used. It is particularly advantageous if a filter tow is made from a Cellulose acetate exists. In the event that a fleece is used, this exists preferably made of paper, but nonwovens made of highly fibrillated can also be used cellulosic fibers or so-called melt-blown nonwovens and spunbonded nonwovens become.
- this preferably contains Staple fibers and / or filaments of a titer of less than 3 dtex, in particular of 1.0 to 2.7 dtex. In this case, a particularly good filter effect is achieved.
- the desired filter effect is also increased by the fact that the filter is ventilated.
- a filter for further explanation of a filter, reference is made to EP-B-0 368 065. From this it is known that in ventilated cigarettes the separation of volatile, especially steam-volatile substances, with increasing degree of ventilation increases. In the context of the invention, it is a degree of ventilation of at least 15%, in particular from 20 to 70%, advantageous.
- the additive is present in the filter cigarette in an amount of less than 15% by mass, based on the fiber weight of the filter.
- This low proportion is surprising and is only possible due to the special filter construction which characterizes the filter cigarette according to the invention.
- This value can be significantly reduced if the additives are selected advantageously. It is possible and advantageous in individual cases if the additive is present in an amount of less than 10% by mass, in particular less than 7% by mass, based on the fiber weight of the filter. The minimum value is about 0.5% by mass, based on the fiber weight of the filter.
- Various groups of compounds which have a selective filtering action against the pyrolysis products of amino acids or proteins can be used here with particular advantage. This includes the connection Tr-P1 etc.
- an additive in the form of an acid, an acidic salt of an acid and / or an acidic carboxylic acid ester b) an additive in the form of a macromolecular, hydrophilic organic compound with internal cavities for complex integration of low-molecular substances, c) an additive in the form of phenolic compounds and / or d) an additive in the form of a complexing agent for low molecular weight substances.
- These groups of compounds include: Group a): acidic citric acid esters (these compounds also act simultaneously as plasticizers for cellulose acetate and can therefore also be applied without problems via the plasticizer dosage, preferably in a mixture with other plasticizers), suberic acid, acidic maleic acid Fumaric acid and / or adipic acid esters, in particular in the form of the alkyl acid esters, among which the methyl and ethyl esters are preferred, b) an additive in the form of poly- and / or oligosaccharides, in particular in the form of activated celluloses and starch derivatives and / or cyclodextrin, wherein the ⁇ -cyclodextrin is particularly preferred, and in the form of a native protein, in particular in the form of ⁇ -lactoglobulin, c) an additive in the form of ellagic acid and / or lignin, and d) an additive in the form of a metal complex of porphyrins, such as
- the filter cigarettes according to the invention can be produced using conventional methods.
- the additive be made from a filter fibrous filter material, in particular in the form of cellulose acetate, in a mixture with a plasticizer, especially in the form of glycerol triacetate, in a conventional Filter rod production is applied.
- the advantages of the invention can be outlined as follows:
- the chosen one Filtration concept allows the required effects to be achieved with a minimal amount of material Achieve additive.
- optimization is possible when additives are out the addressed defined substance groups can be selected to achieve the filter effect to improve.
- This advantage is borne by the knowledge that here one special target group of mutagenic substances must be filtered selectively.
- the effects demonstrated in the Ames test can be higher in cell cultures Organisms, such as the hamster cell test of cell culture V79, in full to verify. This impressively underlines the relevance of the present invention in regarding the question of smoking and health.
- An advantage that should not be underestimated Invention is that a particularly suitable method for the industrial manufacture of Filters are specified without significant modification to existing technologies is feasible.
- a paper from Julius Glatz, Toiletfabriken, Neidenfels, Federal Republic of Germany with the designation F 796-28 was used as filter wrapping paper.
- the additive was applied in a mixture with triacetin by means of the plasticizer dosage. Diethyl citrate (CDE) (Boehringer Mannheim GmbH, Chemische Fabrik, Mannheim, Federal Republic of Germany, Art. 663502) and lignin (lignin organosolv from Aldrich-Chemie, Steinheim, Federal Republic of Germany, Art. 37,101-7) were used as additives.
- the plasticizer was determined by differential weighing of filter rods with and without plasticizer.
- the additive layer was calculated on the basis of the plasticizer layer and the concentration of the plasticizer in the triacetin.
- Table I contains a compilation of the filter rods produced: Name of the sample Titer Tensile resistance (mmWS) Fiber weight (mg) Plasticizer pad (%) Type u. Amount of additive (%) A1.5 1.5 Y 30 SK 462 530 6.9 - A3.0 3.0 Y 35 HK 412 663 7.8 - A8.0 8.0 Y 35 HK 182 638 7.9 - B1.5-1 1.5 Y 30 SK 452 527 8.4 2.6 CDE B1.5-2 1.5 Y 30 SK 465 527 13.9 4.3 CDE B3.0 3.0 Y 35 HK 422 667 8.3 2.5 CDE B8.0 8.0 Y 35 HK 174 636 8.0 2.4 CDE C1.5 1.5 Y 30 SK 457 521 13.8 1.0 lignin C3.0 3.0 Y 35 HK 421 665 13.9 1.0 lignin C8.0 8.0 Y 35 HK 186 651 13.2 1.0 lignin
- the filter rods were cut to a length of 20 mm, glued to the tobacco rod of a CORESTA monitor cigarette and according to CORESTA recommended method No. 22 and 23 smoked.
- the nicotine determination and the determination of the nicotine retention was carried out according to the methods CORESTA recommended method No. 7 and 9.
- the condensate was measured using the Ames test (Maron, Dorothy M. and Ames, Bruce N., Revised methods for the Salmonella mutagenicity test, Mutation Research, 113 (1983) 173-215, taking into account the information contained in the OECD Guideline for Testing of chemicals No. 471 general conditions described on May 26, 1983) tested for their mutagenic effect. All experiments were carried out with the bacterial strain TA 98 with metabolic activation. The condensate extraction for the Ames test was carried out according to the standards CORESTA recommended No. 22 and 23. Since smoking of the experimental cigarettes, due to the unequal filter effectiveness of the Experimental filters, different amounts of condensate are created Condensate solutions brought to an equal concentration by dilution Statement about the specific, i.e.
- the extraction of the smoked Cambridge filter and the dilution will carried out as follows:
- the Cambridge filter is in 50 ml ethanol p.A.
- An aliquot part of the solution is removed and its absorbance UV-spectroscopically at a wavelength of 310 nm determined.
- the original condensate solution is then diluted so that it has an absorbance of 2.0 in purely arithmetical terms. This corresponds to one Wet condensate concentration, depending on the moisture and nicotine content of the wet condensate of about 4 mg / ml ethanol.
- the example shows that by increasing the amount of additive also An increase in the antimutagenic effect is achieved (cf. in particular sample B1.5-2), but that the amount of additive used, in comparison to the known filters with additives, is very low. This means that according to the present invention with relatively small amounts of additive a very high reduction in mutagenicity is achieved.
- the values of the measured nicotine retention for those with B and C Samples labeled are for illustration purposes only. Especially shows up for the samples designated B that, in accordance with the teaching of DE-PS 1 300 854, nicotine retention is significantly increased by diethyl citrate.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Inorganic Chemistry (AREA)
- Cigarettes, Filters, And Manufacturing Of Filters (AREA)
- Fats And Perfumes (AREA)
- Nonwoven Fabrics (AREA)
- Filtering Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19541873 | 1995-11-09 | ||
DE19541873A DE19541873A1 (de) | 1995-11-09 | 1995-11-09 | Filterzigarette |
PCT/EP1996/004733 WO1997016986A1 (de) | 1995-11-09 | 1996-10-31 | Filterzigarette |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0859558A1 EP0859558A1 (de) | 1998-08-26 |
EP0859558B1 true EP0859558B1 (de) | 2000-10-11 |
Family
ID=7777081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP96937308A Expired - Lifetime EP0859558B1 (de) | 1995-11-09 | 1996-10-31 | Filterzigarette |
Country Status (33)
Country | Link |
---|---|
US (1) | US6145511A (uk) |
EP (1) | EP0859558B1 (uk) |
JP (1) | JP3604397B2 (uk) |
KR (1) | KR100265506B1 (uk) |
CN (1) | CN1105518C (uk) |
AT (1) | ATE196829T1 (uk) |
BG (1) | BG63814B1 (uk) |
BR (1) | BR9611382A (uk) |
CA (1) | CA2234795C (uk) |
CZ (1) | CZ294476B6 (uk) |
DE (2) | DE19541873A1 (uk) |
DK (1) | DK0859558T3 (uk) |
EE (1) | EE03660B1 (uk) |
ES (1) | ES2154420T3 (uk) |
GE (1) | GEP20002134B (uk) |
GR (1) | GR3035218T3 (uk) |
HK (1) | HK1016434A1 (uk) |
HU (1) | HUP9903488A3 (uk) |
IL (1) | IL124335A (uk) |
IS (1) | IS1800B (uk) |
LT (1) | LT4447B (uk) |
LV (1) | LV12123B (uk) |
NO (1) | NO306144B1 (uk) |
NZ (1) | NZ321598A (uk) |
PL (1) | PL184287B1 (uk) |
PT (1) | PT859558E (uk) |
RO (1) | RO118922B1 (uk) |
RU (1) | RU2140758C1 (uk) |
SI (1) | SI9620124A (uk) |
SK (1) | SK282028B6 (uk) |
TR (1) | TR199800832T2 (uk) |
UA (1) | UA42853C2 (uk) |
WO (1) | WO1997016986A1 (uk) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2269475A1 (de) | 2009-06-30 | 2011-01-05 | Olig AG | Filter für eine rauchfreie Zigarette |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO983015A (no) * | 1998-06-29 | 1999-11-15 | Mohammad Azam Mansoor | Sigarettfilter som inneholder kjemiske forbindelser |
DE19951062C2 (de) * | 1999-10-22 | 2002-04-04 | Rhodia Acetow Gmbh | Hochleistungs-Zigarettenfilter |
PT1317192E (pt) * | 2000-09-12 | 2007-02-28 | Filligent Ltd | Filtro de fumo de tabaco |
WO2002037990A2 (en) * | 2000-11-10 | 2002-05-16 | Vector Tobacco Ltd. | Method and product for removing carcinogens from tobacco smoke |
US6789546B2 (en) * | 2001-06-26 | 2004-09-14 | Technion Research & Development Foundation Ltd. | Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject |
ES2273220T3 (es) * | 2003-02-18 | 2007-05-01 | Filligent Limited | Filtro que contiene una ftalocianina metalica y un polimero policationico. |
WO2005086915A2 (en) | 2004-03-09 | 2005-09-22 | Arriva Pharmaceuticals, Inc. | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
JP5468736B2 (ja) * | 2004-05-24 | 2014-04-09 | ブリティッシュ アメリカン タバコ (インヴェストメンツ) リミテッド | ニトロサミン類に選択的なモレキュラーインプリントポリマーおよびその使用方法 |
CN1301076C (zh) * | 2004-05-26 | 2007-02-21 | 长沙卷烟厂 | 高分子聚合物卷烟滤嘴添加剂及应用 |
DE102004048651A1 (de) * | 2004-10-06 | 2006-04-13 | Rhodia Acetow Gmbh | Tabakrauchfilter oder -filterelemente mit einem Gehalt an Zusatzstoffen |
CN1762251B (zh) * | 2004-10-18 | 2012-03-14 | 南通醋酸纤维有限公司 | 消除烟气中有害物质的烟用醋酸纤维丝束的生产方法 |
GB0517551D0 (en) * | 2005-08-27 | 2005-10-05 | Acetate Products Ltd | Process for making filter tow |
AR060470A1 (es) * | 2006-04-17 | 2008-06-18 | Filligent Ltd | Metodo y dispositivo para fabricar filtros para humo de tabaco |
KR101055909B1 (ko) | 2008-07-07 | 2011-08-09 | 한현수 | 독성 및 유해가스 여과용 바이오세라믹 촉매 여과물질 및그 제조방법 |
US9386803B2 (en) * | 2010-01-06 | 2016-07-12 | Celanese Acetate Llc | Tobacco smoke filter for smoking device with porous mass of active particulate |
US20120048285A1 (en) * | 2010-03-26 | 2012-03-01 | Philip Morris Usa Inc. | Supramolecular complex flavor immobilization and controlled release |
KR101520198B1 (ko) * | 2010-10-06 | 2015-05-13 | 셀라네세 아세테이트 앨앨씨 | 탄소 입자 로딩 및 캡슐화 압력 강하를 갖는 다공성 매스를 포함한 흡연기용 연기 필터 |
JP5728584B2 (ja) | 2010-10-15 | 2015-06-03 | セラニーズ アセテート,エルエルシー | 煙フィルタ用多孔質体を形成する装置、システム、および関連方法 |
CN102247010B (zh) * | 2011-07-02 | 2013-08-21 | 云南瑞升烟草技术(集团)有限公司 | 一种线状功能型纤维材料在卷烟中的应用 |
US8967155B2 (en) | 2011-11-03 | 2015-03-03 | Celanese Acetate Llc | Products of high denier per filament and low total denier tow bands |
GB2504495A (en) * | 2012-07-30 | 2014-02-05 | British American Tobacco Co | Fleece for smokeless tobacco pouch |
CN103645109A (zh) * | 2013-12-17 | 2014-03-19 | 中国烟草总公司郑州烟草研究院 | 一种卷烟滤嘴中焦油截留效率和焦油截留量的测定方法 |
CN103674877A (zh) * | 2013-12-17 | 2014-03-26 | 中国烟草总公司郑州烟草研究院 | 一种卷烟滤嘴中焦油截留量的测定方法 |
JP6951245B2 (ja) | 2014-12-29 | 2021-10-20 | フィリップ・モーリス・プロダクツ・ソシエテ・アノニム | 疎水性フィルター |
CN105105336A (zh) * | 2015-09-19 | 2015-12-02 | 刘明 | 中药川贝母粒子净化烟气过滤烟嘴 |
CN107746872A (zh) * | 2017-09-21 | 2018-03-02 | 云南中烟工业有限责任公司 | 一种针对电子烟气溶胶水提物的细菌回复突变试验 |
US10798965B2 (en) | 2017-12-12 | 2020-10-13 | Banana Bros, Llc | Multi-stage filtration device |
JP7176885B2 (ja) * | 2018-08-09 | 2022-11-22 | 株式会社ダイセル | セルロースアセテート組成物及び成形体 |
CN111184253B (zh) * | 2018-11-14 | 2022-03-25 | 南通烟滤嘴有限责任公司 | 细支滤棒用丝束规格的选择方法 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1300854B (de) * | 1965-05-14 | 1969-08-07 | Reemtsma H F & Ph | Filter fuer Zigaretten |
JPS50125100A (uk) | 1974-03-19 | 1975-10-01 | ||
JPS5312600B2 (uk) | 1974-06-21 | 1978-05-02 | ||
JPS5132799A (ja) | 1974-09-13 | 1976-03-19 | Toyo Ink Mfg Co | Tabakonokemuryofuirutaa |
CH621051A5 (en) * | 1976-12-15 | 1981-01-15 | Cigarette Components Ltd | Tobacco smoke filter and manufacturing process for this |
JPS5922511B2 (ja) * | 1978-04-22 | 1984-05-26 | ダイセル化学工業株式会社 | たばこ煙用フイルタ− |
JPS5831981A (ja) * | 1981-08-20 | 1983-02-24 | ダイセル化学工業株式会社 | たばこ煙のフイルタ− |
JPS6049476B2 (ja) * | 1983-04-02 | 1985-11-01 | 株式会社ラツクスオ−ド | タバコ喫味調整剤 |
US4729390A (en) * | 1985-07-31 | 1988-03-08 | Eastman Kodak Company | Tobacco smoke filtering material |
WO1987002869A1 (en) | 1985-11-12 | 1987-05-21 | Kabushiki Kaisya Advance | Adsorbent for mutagenic substance contained in tobacco smoke and use thereof |
DE3820089A1 (de) * | 1988-06-13 | 1989-12-14 | Bat Cigarettenfab Gmbh | Verfahren zur impraegnierung von fasern eines tabakrauchfilters mit di- oder polycarbonsaeuren bzw. anhydriden derselben |
US5150721A (en) * | 1990-02-28 | 1992-09-29 | Lee Benedict M | Tobacco smoke filter material and process for production thereof |
JPH0523159A (ja) * | 1991-07-19 | 1993-02-02 | Kikkoman Corp | タバコフイルター |
US5465739A (en) * | 1992-04-15 | 1995-11-14 | R. J. Reynolds Tobacco Company | Cigarette and cigarette filter element therefor |
US5275859A (en) * | 1992-12-21 | 1994-01-04 | Eastman Kodak Company | Tobacco smoke filter |
US5746231A (en) * | 1993-01-11 | 1998-05-05 | Craig Lesser | Tobacco smoke filter for removing toxic compounds |
DE4320384A1 (de) | 1993-06-19 | 1994-12-22 | Mann & Hummel Filter | Aktivkohlefilter zur Kraftstofftankentlüftung |
DE4416101C2 (de) * | 1994-04-19 | 1997-06-12 | Reemtsma H F & Ph | Tabakerzeugnisse oder Tabakerzeugnissen ähnliche Waren mit antioxidativ wirkenden Naturstoffen und Verfahren zur Herstellung derselben |
-
1995
- 1995-11-09 DE DE19541873A patent/DE19541873A1/de not_active Ceased
-
1996
- 1996-10-31 DE DE59605994T patent/DE59605994D1/de not_active Expired - Lifetime
- 1996-10-31 EP EP96937308A patent/EP0859558B1/de not_active Expired - Lifetime
- 1996-10-31 TR TR1998/00832T patent/TR199800832T2/xx unknown
- 1996-10-31 UA UA98052378A patent/UA42853C2/uk unknown
- 1996-10-31 RO RO98-00949A patent/RO118922B1/ro unknown
- 1996-10-31 CN CN96198197A patent/CN1105518C/zh not_active Expired - Fee Related
- 1996-10-31 PL PL96326553A patent/PL184287B1/pl not_active IP Right Cessation
- 1996-10-31 IL IL12433596A patent/IL124335A/xx not_active IP Right Cessation
- 1996-10-31 BR BR9611382-0A patent/BR9611382A/pt not_active IP Right Cessation
- 1996-10-31 DK DK96937308T patent/DK0859558T3/da active
- 1996-10-31 NZ NZ321598A patent/NZ321598A/xx unknown
- 1996-10-31 AT AT96937308T patent/ATE196829T1/de not_active IP Right Cessation
- 1996-10-31 CZ CZ19981420A patent/CZ294476B6/cs not_active IP Right Cessation
- 1996-10-31 PT PT96937308T patent/PT859558E/pt unknown
- 1996-10-31 WO PCT/EP1996/004733 patent/WO1997016986A1/de active IP Right Grant
- 1996-10-31 KR KR1019980703471A patent/KR100265506B1/ko not_active IP Right Cessation
- 1996-10-31 RU RU98110971A patent/RU2140758C1/ru not_active IP Right Cessation
- 1996-10-31 SK SK598-98A patent/SK282028B6/sk not_active IP Right Cessation
- 1996-10-31 JP JP51781297A patent/JP3604397B2/ja not_active Expired - Lifetime
- 1996-10-31 SI SI9620124A patent/SI9620124A/sl not_active IP Right Cessation
- 1996-10-31 EE EE9800152A patent/EE03660B1/xx not_active IP Right Cessation
- 1996-10-31 US US09/068,191 patent/US6145511A/en not_active Expired - Lifetime
- 1996-10-31 ES ES96937308T patent/ES2154420T3/es not_active Expired - Lifetime
- 1996-10-31 GE GEAP19964275A patent/GEP20002134B/en unknown
- 1996-10-31 CA CA002234795A patent/CA2234795C/en not_active Expired - Fee Related
- 1996-10-31 HU HU9903488A patent/HUP9903488A3/hu unknown
-
1998
- 1998-04-23 LV LVP-98-76A patent/LV12123B/lv unknown
- 1998-04-29 BG BG102414A patent/BG63814B1/bg unknown
- 1998-05-07 NO NO982079A patent/NO306144B1/no not_active IP Right Cessation
- 1998-05-07 LT LT98-063A patent/LT4447B/lt not_active IP Right Cessation
- 1998-05-08 IS IS4737A patent/IS1800B/is unknown
-
1999
- 1999-04-21 HK HK99101713A patent/HK1016434A1/xx not_active IP Right Cessation
-
2001
- 2001-01-11 GR GR20010400034T patent/GR3035218T3/el not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2269475A1 (de) | 2009-06-30 | 2011-01-05 | Olig AG | Filter für eine rauchfreie Zigarette |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0859558B1 (de) | Filterzigarette | |
DE68923858T2 (de) | Selektive Abgabe und Retention von Aldehyd und Nikotin-Nebenprodukten aus Zigarettenrauch. | |
EP1796488B1 (de) | Tabakrauchfilter oder-filterelemente mit einem gehalt an zusatzstoffen | |
EP1221869B1 (de) | Hochleistungs-zigarettenfilter | |
EP0632970B1 (de) | Aus Celluloseacetat geformte Gebilde, deren Verwendung zur Herstellung von Filtertow,Verwendung des Filtertows zur Herstellung eines Tabakrauchfilterelements sowie Filtertow und Tabakrauchfilterelement | |
EP0632969B1 (de) | Filtertow und Verfahren zu dessen Herstellung sowie Tabakrauchfilterelement und Verfahren zu dessen Herstellung | |
DE1517265A1 (de) | Zigarettenfilter | |
EP1389922B1 (de) | Filter tow aus gekräuselten, endlosen celluloseacetatfilamenten | |
EP0632968B1 (de) | Filtertow und Verfahren zu dessen Herstellung sowie Tabakrauchfilterelement und Verfahren zu dessen Herstellung | |
WO1993007771A1 (de) | Zigarettenfilter | |
DE60308877T2 (de) | Biologisch abbaubare filterzigarette mit zwei dichten | |
DE3303645A1 (de) | Tabakrauch-filter | |
DE2109919A1 (de) | Filterstrang für Tabakrauchfilter und Verfahren zu seiner Herstellung | |
DE2341685C3 (de) | Zigarettenfilter aus Celluloseacetatfasern und Verfahren zu seiner Herstellung | |
DE2559542C3 (de) | Zigarerfenfilter | |
AT515930B1 (de) | Saugfähiger Artikel und seine Verwendung | |
MXPA98003702A (en) | Cigarette with fil | |
DE1517296A1 (de) | Cigarettenfilter und Verwendung von mit Zuckerestern versetzten Filterelementen | |
DE2362701A1 (de) | Zigarettenfilter und verfahren zu seiner herstellung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19980408 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
17Q | First examination report despatched |
Effective date: 19990707 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: RHODIA ACETOW GMBH |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20001011 |
|
REF | Corresponds to: |
Ref document number: 196829 Country of ref document: AT Date of ref document: 20001015 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: GERMAN |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 20001012 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ISLER & PEDRAZZINI AG |
|
REF | Corresponds to: |
Ref document number: 59605994 Country of ref document: DE Date of ref document: 20001116 |
|
ET | Fr: translation filed | ||
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: THE PATENT HAS BEEN ANNULLED BY A DECISION OF A NATIONAL AUTHORITY Effective date: 20001211 |
|
ITF | It: translation for a ep patent filed | ||
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 20001204 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2154420 Country of ref document: ES Kind code of ref document: T3 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PCAR Free format text: ISLER & PEDRAZZINI AG;POSTFACH 1772;8027 ZUERICH (CH) |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: LU Payment date: 20081027 Year of fee payment: 13 Ref country code: IE Payment date: 20081028 Year of fee payment: 13 Ref country code: DK Payment date: 20081024 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: PT Payment date: 20081028 Year of fee payment: 13 Ref country code: AT Payment date: 20081023 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: BE Payment date: 20081024 Year of fee payment: 13 Ref country code: SE Payment date: 20081027 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20081021 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GR Payment date: 20081031 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20091026 Year of fee payment: 14 Ref country code: CH Payment date: 20091026 Year of fee payment: 14 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20091027 Year of fee payment: 14 |
|
BERE | Be: lapsed |
Owner name: *RHODIA ACETOW G.M.B.H. Effective date: 20091031 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IT Payment date: 20091023 Year of fee payment: 14 Ref country code: GB Payment date: 20091023 Year of fee payment: 14 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 20100430 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
EUG | Se: european patent has lapsed | ||
REG | Reference to a national code |
Ref country code: IE Ref legal event code: MM4A |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20100630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100430 Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091102 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20100504 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091031 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: V1 Effective date: 20110501 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20091101 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20101031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20110501 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20111118 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101031 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20101101 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20111216 Year of fee payment: 16 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20130501 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 59605994 Country of ref document: DE Effective date: 20130501 |